SI-BONE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 99.53K shares, a 6.78% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 7.35K shares, a 63.35% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 89.97K shares, a 4829.81% increase year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 2.50K shares, a 94.13% decline year-over-year.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 205.72K shares, a 43.18% increase from fiscal 2024.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 143.69K shares, a 79.43% decline from fiscal 2023.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 698.63K shares, a 767.09% increase from fiscal 2022.
- SI-BONE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 80.57K shares, a 78.19% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 99.53K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 199.35K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 7.35K shares 10-Q · filed 2026-05-11 | 193.02K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 89.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 205.72K shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 2.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 117.58K shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 93.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | 157.62K shares derived: sum of 4 quarters · filed 2025-08-05 |
| 2025-03-31 | 20.05K shares 10-Q · filed 2025-05-06 | 133.84K shares derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-12-31 | 1.82K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 143.69K shares 10-K · filed 2025-02-25 |
| 2024-09-30 | 42.54K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 169.99K shares derived: sum of 4 quarters · filed 2024-11-12 |
| 2024-06-30 | 69.43K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | 179.75K shares derived: sum of 4 quarters · filed 2024-08-06 |
| 2024-03-31 | 29.89K shares 10-Q · filed 2024-05-07 | 608.25K shares derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | 28.13K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 698.63K shares 10-K · filed 2024-02-27 |
| 2023-09-30 | 52.30K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 686.85K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | 497.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 659.50K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | 120.27K shares 10-Q · filed 2023-05-02 | 166.04K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | 16.36K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 80.57K shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 24.94K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 116.58K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 4.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 173.75K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 34.80K shares 10-Q · filed 2022-05-10 | 310.20K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 52.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 369.38K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 82.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 413.37K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | 140.92K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | 468.65K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-03-31 | 93.97K shares 10-Q · filed 2021-05-04 | 374.34K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-12-31 | 96.37K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 323.70K shares 10-K · filed 2022-03-01 |
| 2020-09-30 | 137.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | 313.06K shares derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-06-30 | 46.61K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 350.74K shares derived: sum of 4 quarters · filed 2021-03-10 |
| 2020-03-31 | 43.33K shares 10-Q · filed 2020-05-05 | 441.31K shares derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-12-31 | 85.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | 444.92K shares 10-K · filed 2021-03-10 |
| 2019-09-30 | 175.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 444.55K shares derived: sum of 4 quarters · filed 2020-03-11 |
| 2019-06-30 | 137.19K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | |
| 2019-03-31 | 46.95K shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 85.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | 395.12K shares 10-K · filed 2020-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |